Dimethicone 50 MG/ML Topical Cream — RxCUI 259090
RxNorm drug concept · Semantic clinical drug
RxCUI 259090
Semantic clinical drug · SCD
● Current RxNorm concept 8 FDA products
9 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI259090
Official nameDimethicone 50 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdimethicone 5 % Topical Cream
FDA products mapped8
Package NDCs mapped9
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Dimethicone 50 MG/ML Topical Cream Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dimethicone 50 MG/ML Topical Cream
RxCUI 259090 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Dimethicone
324072IN
-
Dimethicone
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dimethicone Topical Cream
377680SCDF -
Dimethicone Topical Product
1159485SCDG -
Topical Cream
316982DF -
Topical Product
1151122DFG
-
Dimethicone Topical Cream
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dimethicone 50 MG/ML
331825SCDC
-
Dimethicone 50 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dimethicone 50 MG/ML
SCDC · 331825 -
Dimethicone Topical Cream
SCDF · 377680 -
Dimethicone Topical Product
SCDG · 1159485
📦 FDA Products & Package NDCs
8 products · 9 package NDCs
9 package NDCs map to RxCUI 259090 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 55681-0024-04 | 113 g in 1 TUBE (55681-024-04) | Procure Dimethicone 5% | Twin Med LLC | 2025-06-28 |
| 55681-0024-14 | 144 PACKET in 1 CARTON (55681-024-14) / 5 g in 1 PACKET (55... | Procure Dimethicone 5% | Twin Med LLC | 2025-06-28 |
| 59088-0333-08 | 118 mL in 1 TUBE (59088-333-08) | Skin Repair Complex | PureTek Corporation | 2015-05-01 |
| 59088-0334-00 | 1 KIT in 1 PACKAGE (59088-334-00) * 237 mL in 1 BOTTLE, PL... | DermacinRx Surgical ComboPak | PureTek Corporation | 2015-04-28 |
| 59088-0391-00 | 1 KIT in 1 CARTON (59088-391-00) * 237 mL in 1 BOTTLE, PLA... | DermacinRx Clorhexacin | PureTek Corporation | 2016-06-02 |
| 59088-0623-08 | 118 mL in 1 TUBE (59088-623-08) | Dimopair | PureTek Corporation | 2023-03-29 |
| 59088-0754-00 | 1 KIT in 1 KIT (59088-754-00) * 1 TUBE in 1 CARTON (45802-... | Fluopar | PureTek Corporation | 2020-03-03 |
| 59088-0805-00 | 1 KIT in 1 KIT (59088-805-00) * 118 mL in 1 TUBE (59088-33... | DermacinRx ZRM Pak | PureTek Corporation | 2016-05-12 |
| 69740-0322-00 | 114 g in 1 TUBE (69740-322-00) | Secura Dimethicone Protectant | Smith & Nephew Medical Ltd | 2005-08-01 |
Observed labelers:
PureTek Corporation (6) ·
Twin Med LLC (2) ·
Smith & Nephew Medical Ltd (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.